Back

A Phase 2 Trial of Trientine for Hypertrophic Cardiomyopathy

31 August 2025 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: spectrum of cardiomyopathies Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Christopher Miller

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
EMORI-HCM Electro-Mechanically Optimised RVP For oHCM
Doctor J. Mohal (London, GB)
Slides Video
Presentation thumbnail
REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM trials: Incidence and impact of atrial fibrillation in oHCM with aficamten
Doctor A. Masri (Portland, US)
Slides Video
Presentation thumbnail
Initial findings from MaesTTRo
Doctor M. Grogan (Rochester, US)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: spectrum of cardiomyopathies
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Session
Advances in cardiomyopathies
11 May 2026
thumbnail
Congress Presentation
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in preclinical individuals with an HCM sarcomeric gene mutation
1 September 2024
thumbnail
Congress Presentation
ODYSSEY-HCM: Mavacamten in nHCM
30 August 2025
thumbnail
Congress Presentation
Patient case 2
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources